Holzleitner, N.; Günther, T.; Beck, R.; Lapa, C.; Wester, H.-J.
Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo. Pharmaceuticals 2022, 15, 1467.
https://doi.org/10.3390/ph15121467
AMA Style
Holzleitner N, Günther T, Beck R, Lapa C, Wester H-J.
Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo. Pharmaceuticals. 2022; 15(12):1467.
https://doi.org/10.3390/ph15121467
Chicago/Turabian Style
Holzleitner, Nadine, Thomas Günther, Roswitha Beck, Constantin Lapa, and Hans-Jürgen Wester.
2022. "Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo" Pharmaceuticals 15, no. 12: 1467.
https://doi.org/10.3390/ph15121467
APA Style
Holzleitner, N., Günther, T., Beck, R., Lapa, C., & Wester, H.-J.
(2022). Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo. Pharmaceuticals, 15(12), 1467.
https://doi.org/10.3390/ph15121467